# Aspirin for Prevention of Preeclampsia

> **NCT03726177** · NA · UNKNOWN · sponsor: **Aswan University Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** aspirin 162 mg
- **DRUG:** aspirin 81 mg
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03726177
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-01-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03726177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03726177, "Aspirin for Prevention of Preeclampsia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03726177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*